1. Identification of plasma biomarker candidates in glioblastoma using an antibody-array-based proteomic approachKlemen Zupančič, Andrej Blejec, Ana Herman, Matija Veber, Urška Verbovšek, Marjan Koršič, Miomir Knežević, Primož Rožman, Tamara Lah Turnšek, Kristina Gruden, Helena Motaln, 2014, izvirni znanstveni članek Povzetek: Background. Glioblastoma multiforme (GBM) is a brain tumour with a very high patient mortality rate, with a median survival of 47 weeks. This might be improved by the identification of novel diagnostic, prognostic and predictive therapy-response biomarkers, preferentially through the monitoring of the patient blood. The aim of this study was to define the impact of GBM in terms of alterations of the plasma protein levels in these patients. Materials and methods. We used a commercially available antibody array that includes 656 antibodies to analyse blood plasma samples from 17 healthy volunteers in comparison with 17 blood plasma samples from patients with GBM. Results. We identified 11 plasma proteins that are statistically most strongly associated with the presence of GBM. These proteins belong to three functional signalling pathways: T-cell signalling and immune responses; cell adhesion and migration; and cell-cycle control and apoptosis. Thus, we can consider this identified set of proteins as potential diagnostic biomarker candidates for GBM. In addition, a set of 16 plasma proteins were significantly associated with the overall survival of these patients with GBM. Guanine nucleotide binding protein alpha (GNAO1) was associated with both GBM presence and survival of patients with GBM. Conclusions. Antibody array analysis represents a useful tool for the screening of plasma samples for potential cancer biomarker candidates in small-scale exploratory experiments; however, clinical validation of these candidates requires their further evaluation in a larger study on an independent cohort of patients.
Ključne besede: glioblastoma, proteomics, biomarker
Objavljeno v DiRROS: 16.04.2024; Ogledov: 284; Prenosov: 316
 Celotno besedilo (620,85 KB)
Gradivo ima več datotek! Več... |
2. |
3. Incidenca raka v prvem letu epidemije covida-19Vesna Zadnik, Tina Žagar, Nika Bric, Mojca Birk, Amela Duratović Konjević, Ana Mihor, Katarina Lokar, Sonja Tomšič, 2023, strokovni članek Povzetek: Uvod: Število novih diagnoz raka (incidenca) se v Sloveniji v zadnjem desetletju povečuje za povprečno 1,6 % na leto. V letu 2020, prvem letu omejitvenih ukrepov zaradi epidemije covida19, smo s platformo OnKOvid predvideli 3–8-odstotni padec novih diagnoz raka. Namen je predstaviti uradno incidenco raka za Slovenijo za leto 2020 in ugotoviti, kolikšen je bil dejansko manko novih diagnoz raka. Metode: V Registru raka Republike Slovenije smo v skladu z mednarodnimi pravili registrirali vse nove primere raka pri prebivalcih s stalnim prebivališčem v Sloveniji. Primerjali smo jih z registrirano incidenco za 2019, modelno incidenco za 2020, preliminarnimi rezultati OnKovida in dostopnimi rezultati incidence iz registrov raka iz drugih držav. Rezultati: V letu 2020 je za rakom zbolelo 15.096 oseb v Sloveniji (7.034 žensk, 8.002 moška). Glede na modelno oceno incidence za leto 2020 gre za manko 1.854 oseb (10,9 %; 11,6 % žensk, 10,4 % moških). Pri tem je za 10,5 % manj ugotovljenih rakov v omejenem stadiju, najbolj izrazito v starosti 50–69 let (za 13,2 %). Upad je primerljiv s poročili iz Anglije, ZDA in Kanade ter deloma večji kot na Škotskem in Švedskem. Najbolj izrazit upad novih diagnoz raka ugotavljamo pri nemelanomskem kožnem raku (23 %, najbolj po 50. letu), raku prostate (15,9 %, najbolj v omejenem stadiju), pljučnem raku (8,9 %, 60–64 let, v razširjenem stadiju), raku dojk (8,3 %, 45–64 let), ne-Hodgkinovem limfomu (9 %) in levkemijah (11,6 %). Pri kožnem melanomu, raku debelega črevesa in danke ni bilo primanjkljaja. Zaključek: Upad incidence raka v letu 2020 gre verjetno na račun omejitvenih ukrepov, reorganizacije zdravstva in z zdravjem povezanega vedenja med epidemijo covida-19, beležijo jo v več državah. Med epidemijami je potrebno nemoteno izvajanje onkologije.
Ključne besede: rak, incidenca, register raka, epidemija, covid-19
Objavljeno v DiRROS: 26.02.2024; Ogledov: 178; Prenosov: 36
Celotno besedilo (301,68 KB) |
4. Rituximab affects the prognosis of patients with nonHodgkin's lymphomasBarbara Jezeršek Novaković, Marjeta Vovk, Simona Borštnar, Radka Tomšič, 2004, izvirni znanstveni članek Povzetek: Backround. Rituximab - the most widely used monoclonal antibody in the B cell lymphoid malignancies has been applied successfully in the treatment of relapsed and refractory indolent CD20 positive B cell lymphomas and more recently, also in the treatment of aggressive lymphomas in combination with standard chemotherapy. Albeit the chemo-immunotherapy has a wide range of potential applications, there are still several issues that have to be resolved: (1) the optimal scheduling of antibody-chemotherapy combinations, (2) the most active of these combinations, as well as (3) the predictors of response to rituximab. Patients and methods. To facilitate addressing the first two questions, we performed an analysis in 25 patients with different histological types of CD20 positive nonHodgkin's lymphomas (10 aggressive and 15 indolent). Seventeen patients were treated with chemo-immunotherapy for a relapse, and just in 8 patients rituximab was added to first line chemotherapy. Most of the responders received the CHOP regimen, but also otherregimens (FC, BVCPP) were effective in combination with rituximab. Results. The overall response rate was 76%, with 68% complete remissions. The median response duration has not been reached yet. The response was markedly better in the group of previously untreated patients, where the overall response rate reached 100%, with 7 patients in complete and 1 patient in partial remission. Most of the treatment failures occurred in heavily pretreated patients with aggressive lymphomas. No serious adverse effects wereobserved. Conclusion The chemo-immunotherapy improves the treatment outcomes in patients with untreated and relapsed CD20 positive nonHodgkin's lymphomas in comparison to chemotherapy alone. The combined treatment is the most effective when used as soon as possible (preferably as the first line treatment). (Abstract truncated at 2000 characters).
Objavljeno v DiRROS: 07.02.2024; Ogledov: 220; Prenosov: 47
Celotno besedilo (4,61 MB) |
5. First experiences in the development of slovenian sustainable building indicatorsSabina Jordan, Friderik Knez, Miha Tomšič, Marjana Šijanec-Zavrl, 2020, objavljeni znanstveni prispevek na konferenci Povzetek: The construction sector is recognised as having a key impact on the life on Earth. Consequently, the EU has set clear environmental goals for 2030 and 2050, and is developing policies and tools to achieve them. One of the tools for achieving these goals is to establish a system for the evaluation of the environmental performance of buildings, with the priorities of reducing GHG emissions, saving with natural resources and preserving the environment, while maintaining sustainable development and ensuring a healthy living environment. Slovenia has joined in achieving this goal with a study on the state-of-play, commissioned a few years ago by the Ministry of the Environment and Spatial Planning, as the starting point for the development of sustainable building indicators (SBIs). The research, which included an analysis of the Slovenian legislation, commercial certification systems for sustainable buildings and development in the field of green public procurement, exposed complementary but rather different goals and views. It further showed that the Level(s), which provides a common EU approach in assessing the environmental performance of buildings, seems to be the most appropriate framework and the basis for the development of the Slovenian system of SBIs. The development of the Slovenian SBIs is currently underway within the project LIFE IP CARE4CLIMATE with the preparation of guidelines, data sources and procedures for determining the value of individual indicators for the assessment of buildings. Initial research with key construction stakeholders has shown that the solution must be linked to the national building legislation, computational methods and software tools, and also to the established planning procedures. The analyses have also shown that, parallel to developing such a system, it is essential to provide a functional supporting environment and a specific, purposely designed information platform to connect the stakeholders with the developers of the sustainable building indicators system.
Ključne besede: sustainable building indicators, evaluation, assessment, Level(s), CARE4CLIMATE
Objavljeno v DiRROS: 19.01.2024; Ogledov: 164; Prenosov: 81
Celotno besedilo (18,89 MB)
Gradivo ima več datotek! Več... |
6. |
7. |
8. Initial experiences of the first version of Slovene sustainable building Indicators that are based on Level(s)Sabina Jordan, Miha Tomšič, Friderik Knez, Marjana Šijanec-Zavrl, 2023, izvirni znanstveni članek Povzetek: To determine the possibilities for the implementation of sustainable building indicators in Slovenia, testing of the first version of the indicators, developed in the CARE4CLIMATE project and based on the EU Level(s) framework, was carried out in 2022. Invited and interested stakeholders of the construction process were provided with video content and instructions on the Slovenian e-platform of sustainable building indicators. In addition, workshops and lectures with individual subjects were also performed. The final phase of the training and testing procedure included a questionnaire, which was used to obtain information about the participants' opinions regarding the indicators. The analysis of the results of the testing, which was focused on level 2, confirmed the key preliminary finding of the development group, namely that currently, due to the lack of certain knowledge, data, and tools, all indicators for this level are not yet feasible in practice. The research also highlighted the greater need for training and specialization of experts in this field. At the same time, it showed that the testing of the first version itself was a big challenge: only 30 experts fully participated and filled out the online questionnaire. This number seems alarmingly low at first glance, but compared to level(s) testing in the EU member states, it is much more than 50 times higher. However, for the further execution of the indicators in Slovenia, it will therefore be necessary to invest a lot of effort and engagement. It is likely that state support will also be needed, for example, in the form of financial mechanisms or incentives and/or legislative background.
Ključne besede: sustainability, building, indicators, implementation, testing, questionnaire
Objavljeno v DiRROS: 04.01.2024; Ogledov: 221; Prenosov: 94
Celotno besedilo (290,30 KB)
Gradivo ima več datotek! Več... |
9. |
10. Colorimetric cutoff indication of relative humidity based on selectively functionalized mesoporous silicaErika Švara Fabjan, Peter Nadrah, Anja Ajdovec, Matija Tomšič, Goran Dražić, Matjaž Mazaj, Nataša Zabukovec Logar, Andrijana Sever Škapin, 2020, izvirni znanstveni članek Povzetek: We present a novel % cutoff concept of colorimetric indication of relative humidity based on dye dissolution in condensed water in capillaries of selectively functionalized mesoporours host SiO2 material. Consistently high levels of indoor air humidity induces mold and algae growth which represent a potential risks for human health and have deteriorating effect on walls as well. Simple localized humidity detection of high humidity with naked eye especially at places with low air circulation, where growth of mold usually starts first, is therefore highly desirable. The reporting dye was integrated in the non-functionalized mesoporous silica matrix with different pore diameters and selective-functionalized mesoporous silica material. After exposure to the environment of different air humidities the dye dissolved in water causing color change of adsorbent. With the use of adsorbents with different mesopore diameters high ability to tune the value of relative humidity when complete capillary condensation occurred was achieved. Materials with pore diameters of 3.0%nm, 3.5%nm and 7.0%nm exhibit gradual color change when reaching relative humidity up to 55, 79 and 88 RH% respectively. After selective methylation of the material with 7.0%nm pore diameter, non-gradual cutoff color change was achieved. Sample exhibited color change at narrow range of relative humidity (cutoff color change). Due to selective functionalized outer surface the dye dissolution occur only in condensed water in pores and therefore provide colorimetric indication only in this range. Selectively modified silica material has a great potential for a straightforward detection of high humid environment.
Ključne besede: turn-on colorimetric probe, selective functionalization, mesoporous silica, relative humidity, capillary condensation
Objavljeno v DiRROS: 05.09.2023; Ogledov: 319; Prenosov: 233
Celotno besedilo (7,18 MB)
Gradivo ima več datotek! Več... |
